QLAIRA cpr pell 28 pce

7680588580014 CH-58858 G03AB08 09.02.1.
QLAIRA cpr pell 28 pce
QLAIRA cpr pell 28 pce
QLAIRA cpr pell 28 pce
1 / 3
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5885801
CPT
-
Packaging group
1 x 28
Unit
Dragée(s)
Composition
I) dunkelgelbe Tablette: estradioli valeras 3.000 mg, lactosum monohydricum 48.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (flavum), pro compresso obducto. II) mittelrote Tablette: estradioli valeras 2.000 mg, dienogestum 2.000 mg, lactosum monohydricum 47.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (rubrum), pro compresso obducto. III) hellgelbe Tablette: estradioli valeras 2.000 mg, dienogestum 3.000 mg, lactosum monohydricum 46.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (flavum), pro compresso obducto. IV) dunkelrote Tablette: estradioli valeras 1.000 mg, lactosum monohydricum 50.360 mg, maydis amylum, amylum pregelificatum, povidonum K 25, magnesii stearas, hypromellosum, macrogolum 6000, talcum, E 171, E 172 (rubrum), pro compresso obducto. V) weisse Placebotablette: lactosum monohydricum 52.1455 mg, maydis amylum, povidonum K 25, magnesii stearas, hypromellosum, talcum, E 171, pro compresso obducto.

Articles (1)

Qlaira, Filmtabletten
Filmtabletten
1 x 28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/04/2025
Patient information leaflet
Français
17/04/2025
Patient information leaflet
Italien
17/04/2025
Professional SmPC
Allemand
17/04/2025
Professional SmPC
Français
17/04/2025
Professional SmPC
Italien
17/04/2025

Detailed composition

Substance Quantity Type Category
estradioli valeras
1.0 MG Substance Wirkstoff (Principe actif)
estradioli valeras
2.0 MG Substance Wirkstoff (Principe actif)
estradioli valeras
2.0 MG Substance Wirkstoff (Principe actif)
estradioli valeras
3.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
52.1455 MG Substance HBESI
maydis amylum
- Substance HNIDK
dienogestum
3.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
50.36 MG Substance HBESI
lactosum monohydricum
48.36 MG Substance HBESI
dienogestum
2.0 MG Substance Wirkstoff (Principe actif)
maydis amylum
- Substance HNIDK
lactosum monohydricum
46.36 MG Substance HBESI
povidonum K 25
- Substance HNIDK
lactosum monohydricum
47.36 MG Substance HBESI
maydis amylum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
maydis amylum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
maydis amylum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
hypromellosum
- Substance HNIDK
povidonum K 25
- Substance HNIDK
povidonum K 25
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
povidonum K 25
- Substance HNIDK
povidonum K 25
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
talcum
- Substance HNIDK
hypromellosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
58858
Drug name
Qlaira, Filmtabletten
Galenic form
FILM
ATC Code
G03AB08
Authorization status
Z
Dispensation category
B
First authorization
17/09/2009
Authorization expiration date
31/12/9999
IT number
09.02.1.
Domain
Human medicine
Field of application
Orale Kontrazeption

Packaging details

Description (FR)
QLAIRA cpr pell 28 pce
Description (DE)
QLAIRA Filmtabl 28 Stk
Market launch
17/09/2009
Narcotic (BTM)
No

Other packaging sizes

QLAIRA cpr pell 3 x 28 pce
3 x 28 DRG
View
QLAIRA cpr pell 6 x 28 pce
6 x 28 DRG
View
Buy us a coffee Explore the data